| |  |  |  |  |  |  |  |  |  | | From left: Bufferin A analgesics, New Guromont tonic and nutrients, Stoppa A Anti-Diarrhea Medicine, Smile 40EX eyedrops, Halix ID Clear Plaster analgesic and anti-inflammatory poultices, Valsan SP Jet insecticides |  | | Lion pursues a mission of helping people lead healthy and comfortable lives. In line with this mission, Lion is more aggressively pursuing its OTC drug business as another business pillar, to accompany the Home Products operations. Acquired at the end of 2004, this new business is growing steadily and contributing to the bottom line. |  | Segment Sales (Consolidated) For Fiscal Year Ending December 31, 2005
|  |  | | Three-Year Summary: Net Sales (Consolidated) |  |  |  | | Three-Year Summary: Operating Income (Consolidated) |  |  |  |  | * | The operating incomes cited above are the amounts before elimination and the deduction of unallocable operating expenses, which are included in the total figures for the company. For this reason, the sum of all the segments' operating incomes does not equal the consolidated operating income for the company. |  | | | |  | | Message | Amid Japan's rising need for self-medication products, Lion offers therapeutic products, as well as over-the-counter (OTC) pharmaceuticals that prevent illness and enhance quality of life, by accurately grasping the needs of its customer base while expanding its business.
| 2005 Results 2006 Outlook | |